---
figid: PMC9091114__ajtr0014-2550-f5
pmcid: PMC9091114
image_filename: ajtr0014-2550-f5.jpg
figure_link: /pmc/articles/PMC9091114/figure/fig05/
number: Figure 5
figure_title: ''
caption: 'EGFR was the downstream target of miR-671-5p. A: Intersection of target
  genes from miRDB, TargetScan, RNA22 and StarBase; B: KEGG pathway enrichment analysis;
  C: Protein-protein interaction; D: Specific binding site of miR-671-5p and EGFR;
  E: Targeted binding relationship between miR-671-5p and EFGR verified by dual-luciferase
  reporter assay; F, G: Expression of EGFR in BC tissues and correlation analysis
  of EGFR with circ_0001946 and miR-671-5p; H: Expression levels of EGFR in different
  drug-resistant cell lines measured by qRT-PCR and Western blot. Compared to Normal
  group, *P<0.05; compared to mimic-NC group, @P<0.05; compared to MCF7 group, %P<0.05;
  compared to MDA-MB-231 group, &P<0.05. EGFR: epidermal growth factor receptor.'
article_title: YY1 as a promoter regulating the circ_0001946/miR-671-5p/EGFR axis
  to promote chemotherapy resistance in breast cancer cells.
citation: Ge Gao, et al. Am J Transl Res. 2022;14(4):2550-2566.
year: '2022'

doi: ''
journal_title: American Journal of Translational Research
journal_nlm_ta: Am J Transl Res
publisher_name: e-Century Publishing Corporation

keywords:
- circ_0001946
- miR-671-5p
- epidermal growth factor receptor (EGFR)
- tamoxifen

---
